These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 429516)

  • 21. Pressor factors and cardiovascular pressor responsiveness in borderline hypertension.
    Meier A; Weidmann P; Grimm M; Keusch G; Glück Z; Minder I; Ziegler WH
    Hypertension; 1981; 3(3):367-72. PubMed ID: 7019068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of tyramine on blood pressure and plasma catecholamines in normal and hypertensive subjects.
    Bianchetti MG; Minder I; Beretta-Piccoli C; Meier A; Weidmann P
    Klin Wochenschr; 1982 May; 60(9):465-70. PubMed ID: 7045511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sympathetic nerve hyperactivity in high-renin hypertension effects of saralasin infusion.
    DeQuattro V; Barbour BH; Campese V; Finck EJ; Miano L; Esler M
    Mayo Clin Proc; 1977 Jun; 52(6):369-73. PubMed ID: 865132
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High salt intake blunts plasma catecholamine and renin responses to exercise: less suppressive epinephrine in borderline essential hypertension.
    Block LH; Lütold BE; Bolli P; Kiowski W; Bühler FR
    J Cardiovasc Pharmacol; 1984; 6 Suppl 1():S95-100. PubMed ID: 6204165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A long-term study of plasma catecholamine levels and plasma renin activity in borderline hypertension.
    Böhm RO; van Baak MA; van Hooff ME; Mooy J; Rahn KH
    J Hypertens; 1987 Dec; 5(6):655-61. PubMed ID: 3323317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Norepinephrine clearance and pressor effect in normal and hypertensive man.
    Grimm M; Weidmann P; Keusch G; Meier A; Glück Z
    Klin Wochenschr; 1980 Nov; 58(21):1175-81. PubMed ID: 7453102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma norepinephrine and dietary sodium intake in normal subjects and patients with essential hypertension.
    Masuo K; Ogihara T; Kumahara Y; Yamatodani A; Wada H
    Hypertension; 1983; 5(5):767-71. PubMed ID: 6618639
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypertension associated with alcohol withdrawal: assessment of mechanisms and complications.
    Clark LT; Friedman HS
    Alcohol Clin Exp Res; 1985; 9(2):125-30. PubMed ID: 3890591
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epinephrine and norepinephrine pattern in elderly patients with borderline and established hypertension.
    Cerasola G; Cottone S; D'Ignoto G; Grasso L; Carone MB
    Clin Exp Hypertens A; 1989; 11 Suppl 1():371-8. PubMed ID: 2663250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in plasma norepinephrine, blood pressure and heart rate during physical activity in hypertensive man.
    Watson RD; Hamilton CA; Reid JL; Littler WA
    Hypertension; 1979; 1(4):341-6. PubMed ID: 541038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between plasma catecholamines and urinary catecholamine excretion rates in normal subjects and certain diseased states.
    Schiffl H; Weidmann P; Meier A; Ziegler WH
    Klin Wochenschr; 1981 Aug; 59(15):837-44. PubMed ID: 7021996
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathophysiologic features of hypertension in young men.
    de Leeuw PW; Kho TL; Birkenhäger WH
    Chest; 1983 Feb; 83(2 Suppl):312-4. PubMed ID: 6337024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Postprandial changes in noradrenergic and dopaminergic activity in patients with essential hypertension.
    Ishii H; Shigetomi S; Niimura S; Sanada H; Fukuchi S
    Hypertens Res; 1995 Jun; 18 Suppl 1():S199-200. PubMed ID: 8529062
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dissociation of biochemical and hypotensive effects of debrisoquine in hypertensive patients.
    Silas JH; Jones J; Tucker GT; Townshend MM; Phillips CA; Smith AJ
    Eur J Clin Pharmacol; 1979 Sep; 16(2):81-6. PubMed ID: 499312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Essential hypertension: central and peripheral norepinephrine.
    Lake CR; Gullner HG; Polinsky RJ; Ebert MH; Ziegler MG; Bartter FC
    Science; 1981 Feb; 211(4485):955-7. PubMed ID: 7466370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relaxation therapy lowers blood pressure more effectively in hypertensives with raised plasma norepinephrine and blunts pressor response to anger.
    Lee DD; Kimura S; DeQuattro V; Davison G
    Clin Exp Hypertens A; 1989; 11 Suppl 1():191-8. PubMed ID: 2663247
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The pathophysiological role of blood ionized calcium in essential hypertension.
    Shibata S; Kikuchi K; Yamaji I; Nozawa A; Nishimura M; Aoki K; Hasegawa T; Komura H; Suzuki S; Yamamoto M
    Jpn Circ J; 1987 Oct; 51(10):1223-5. PubMed ID: 3323559
    [No Abstract]   [Full Text] [Related]  

  • 38. Personality and adrenergic factors in essential hypertension.
    Perini C; Amann FW; Bolli P; Bühler FR
    Contrib Nephrol; 1982; 30():64-9. PubMed ID: 6749412
    [No Abstract]   [Full Text] [Related]  

  • 39. [Adrenalin and noradrenalin determinations in blood plasma in severe pre-eclampsias and essential hypertension].
    HOCHULI E
    Klin Wochenschr; 1959 Nov; 37():1196. PubMed ID: 14402200
    [No Abstract]   [Full Text] [Related]  

  • 40. The relation of angiotonin and 1-norepinephrine to essential hypertension as determinded by the reaction of the nailfold capillary bed.
    GREISMAN SE
    J Exp Med; 1956 Apr; 103(4):477-86. PubMed ID: 13306856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.